Scott Waldman

Scott Waldman is an Operating Partner at NewVale Capital.

Scott brings more than 25 years of experience in pharmaceutical manufacturing and strategy to NewVale. He served as Senior Vice President and Head of Corporate Development at Curia, a private equity-backed CDMO. Prior to that, he was Chief Strategy Officer and Head of M&A at Lonza, the industry’s largest contract manufacturer.

Scott holds a BS in Accounting from Binghamton University and a JD from NYU School of Law.